| Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups M Schaefer, F Schmidt, C Folwaczny, R Lorenz, G Martin, N Schindlbeck, ... Hepatology 37 (2), 443-451, 2003 | 467 | 2003 |
| Reduction of physiological stress by urban green space in a multisensory virtual experiment M Hedblom, B Gunnarsson, B Iravani, I Knez, M Schaefer, P Thorsson, ... Scientific reports 9 (1), 10113, 2019 | 432 | 2019 |
| Interferon alpha (IFNα) and psychiatric syndromes: a review M Schaefer, MA Engelbrechta, O Gut, BL Fiebich, J Bauer, F Schmidt, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 26 (4), 731-746, 2002 | 294 | 2002 |
| Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement M Schaefer, L Capuron, A Friebe, C Diez-Quevedo, G Robaeys, S Neri, ... Journal of hepatology 57 (6), 1379-1390, 2012 | 282 | 2012 |
| Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C M Schaefer, M Schwaiger, AS Garkisch, M Pich, A Hinzpeter, ... Journal of hepatology 42 (6), 793-798, 2005 | 235 | 2005 |
| Recommendations for the management of hepatitis C virus infection among people who inject drugs J Grebely, G Robaeys, P Bruggmann, A Aghemo, M Backmund, ... International Journal of Drug Policy 26 (10), 1028-1038, 2015 | 216 | 2015 |
| Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D2 receptor gene M Schäfer, D Rujescu, I Giegling, A Guntermann, A Erfurth, B Bondy, ... American Journal of Psychiatry 158 (5), 802-804, 2001 | 205 | 2001 |
| Hepatitis C treatment in “difficult‐to‐treat” psychiatric patients with pegylated interferon‐alpha and ribavirin: response and psychiatric side effects M Schaefer, A Hinzpeter, A Mohmand, G Janssen, M Pich, M Schwaiger, ... Hepatology 46 (4), 991-998, 2007 | 196 | 2007 |
| Bipartite interactions, antibiotic production and biosynthetic potential of the Arabidopsis leaf microbiome EJN Helfrich, CM Vogel, R Ueoka, M Schäfer, F Ryffel, DB Müller, ... Nature Microbiology 3 (8), 909-919, 2018 | 194 | 2018 |
| Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? M Schaefer, A Heinz, M Backmund Addiction 99 (9), 1167-1175, 2004 | 170 | 2004 |
| Recommendations for the management of hepatitis C virus infection among people who inject drugs G Robaeys, J Grebely, S Mauss, P Bruggmann, J Moussalli, A De Gottardi, ... Clinical Infectious Diseases 57 (suppl_2), S129-S137, 2013 | 135 | 2013 |
| Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study … HU Wittchen, SM Apelt, M Soyka, M Gastpar, M Backmund, J Gölz, ... Drug and alcohol dependence 95 (3), 245-257, 2008 | 124 | 2008 |
| Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study K Lieb, MA Engelbrecht, O Gut, BL Fiebich, J Bauer, G Janssen, ... European psychiatry 21 (3), 204-210, 2006 | 115 | 2006 |
| Protective role of the Arabidopsis leaf microbiota against a bacterial pathogen CM Vogel, DB Potthoff, M Schäfer, N Barandun, JA Vorholt Nature microbiology 6 (12), 1537-1548, 2021 | 112 | 2021 |
| Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design HCR Grunze, C Normann, J Langosch, M Schaefer, B Amann, A Sterr, ... Journal of Clinical Psychiatry 62 (6), 464-468, 2001 | 104 | 2001 |
| Neurotransmitter changes by interferon-alpha and therapeutic implications M Schaefer, M Schwaiger, M Pich, K Lieb, A Heinz Pharmacopsychiatry 36 (S 3), 203-206, 2003 | 102 | 2003 |
| Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of … K Merritt, PK McGuire, A Egerton, A Aleman, W Block, OJN Bloemen, ... JAMA psychiatry 78 (6), 667-681, 2021 | 98 | 2021 |
| Neurobiological correlates of the disposition and maintenance of alcoholism A Heinz, M Schäfer, JD Higley, JH Krystal, D Goldman Pharmacopsychiatry 36 (S 3), 255-258, 2003 | 92 | 2003 |
| Escitalopram for the prevention of peginterferon-α2a–associated depression in hepatitis C virus–infected patients without previous psychiatric disease: a randomized trial M Schaefer, R Sarkar, V Knop, S Effenberger, A Friebe, L Heinze, ... Annals of internal medicine 157 (2), 94-103, 2012 | 91 | 2012 |
| Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on‐off‐on design B Hummel, J Walden, R Stampfer, S Dittmann, B Amann, A Sterr, ... Bipolar disorders 4 (6), 412-417, 2002 | 91 | 2002 |
Andreas HeinzMD PhD, Professor of Psychiatry, Director and Chair, Dept. of Psychiatry and Neurosciences, CharitéAdresă de e-mail confirmată pe charite.de